RJA
QDEL icon

Raymond James & Associates’s QuidelOrtho QDEL Stock Holding History

Raymond James & Associates’s Portfolio QDEL Stock Details QDEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.18M Buy
25,875
+19,824
+328% +$802K ﹤0.01% 2584
2024
Q2 		$201K Sell
6,051
-8,848
-59% -$362K ﹤0.01% 3602
2024
Q1 		$714K Sell
14,899
-24,260
-62% -$1.41M ﹤0.01% 2826
2023
Q4 		$2.89M Sell
39,159
-7,141
-15% -$483K ﹤0.01% 1871
2023
Q3 		$3.38M Buy
46,300
+14,537
+46% +$1.16M ﹤0.01% 1706
2023
Q2 		$2.63M Sell
31,763
-1,678
-5% -$147K ﹤0.01% 1888
2023
Q1 		$2.98M Buy
33,441
+4,270
+15% +$372K ﹤0.01% 1805
2022
Q4 		$2.5M Buy
29,171
+5,810
+25% +$492K ﹤0.01% 1853
2022
Q3 		$1.67M Buy
23,361
+8,247
+55% +$738K ﹤0.01% 2081
2022
Q2 		$1.47M Buy
15,114
+4,460
+42% +$455K ﹤0.01% 2198
2022
Q1 		$1.2M Buy
10,654
+2,476
+30% +$264K ﹤0.01% 2473
2021
Q4 		$1.1M Sell
8,178
-2,697
-25% -$375K ﹤0.01% 2555
2021
Q3 		$1.53M Sell
10,875
-20,313
-65% -$2.73M ﹤0.01% 2284
2021
Q2 		$4M Sell
31,188
-61
-0.2% -$7.18K ﹤0.01% 1635
2021
Q1 		$4M Buy
31,249
+14,436
+86% +$2.67M ﹤0.01% 1572
2020
Q4 		$3.02M Sell
16,813
-17,660
-51% -$3.92M ﹤0.01% 1631
2020
Q3 		$7.56M Buy
34,473
+13,029
+61% +$2.91M 0.01% 1003
2020
Q2 		$4.8M Sell
21,444
-6,744
-24% -$1.06M 0.01% 1207
2020
Q1 		$2.76M Buy
28,188
+17,372
+161% +$1.41M ﹤0.01% 1389
2019
Q4 		$812K Sell
10,816
-1,314
-11% -$84.9K ﹤0.01% 2409
2019
Q3 		$744K Sell
12,130
-4,974
-29% -$299K ﹤0.01% 2374
2019
Q2 		$1.01M Sell
17,104
-5,236
-23% -$314K ﹤0.01% 2206
2019
Q1 		$1.46M Sell
22,340
-354
-2% -$21.4K ﹤0.01% 1972
2018
Q4 		$1.11M Sell
22,694
-11,181
-33% -$667K ﹤0.01% 2024
2018
Q3 		$2.21M Buy
33,875
+17,884
+112% +$1.25M ﹤0.01% 1749
2018
Q2 		$1.06M Sell
15,991
-18,026
-53% -$1.09M ﹤0.01% 2166
2018
Q1 		$1.76M Buy
+34,017
New +$1.58M ﹤0.01% 1781

Other funds holding QDEL

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Raymond James & Associates's QDEL Position: Q3 2024 in Review

Raymond James & Associates increased its QuidelOrtho (QDEL) stake by 328% in Q3 2024, buying an estimated $802K and bringing the position to 25,875 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2584.

Raymond James & Associates first reported a position in QDEL in Q1 2018 and has held it in 27 quarters since. The position peaked at $7.56M in Q3 2020. 263 funds tracked by Wall St. Rank hold QDEL as of Q3 2024.

  • Raymond James & Associates held 25,875 shares of QuidelOrtho worth $1.18M as of Q3 2024.
  • Raymond James & Associates bought 19,824 QuidelOrtho shares in Q3 2024, an estimated $802K.
  • QuidelOrtho made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2584 holding.
  • Raymond James & Associates first reported a position in QuidelOrtho in Q1 2018 and has held it in 27 quarters since.
  • Raymond James & Associates's QuidelOrtho position peaked at $7.56M in Q3 2020.
  • 263 funds tracked by Wall St. Rank held QuidelOrtho as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.